[1] CHEN S, ZHAO X, CHEN J, et al. Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release [J]. Bioconjug Chem, 2010, 21(5): 979-987.
[2] LIN Y. Investigation of correlation between expression of glvoma diphtheria toxin receptor and pathological grade of glioma[D]. Shengyang： China Medical University， 2009.
[3] YANG W, MOU T, ZHANG X, et al. Synthesis and biological evaluation of 99mTc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent [J]. Appl Radiat Isot, 2010, 68(1): 105-109.
[4] LIU Y, LI K, PAN J, et al. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxel [J]. Biomaterials, 2010, 31(2): 330-338.
[5] OH S, KIM B J, SINGH N P, et al. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide [J]. Cancer Lett, 2009, 274(1): 33-39.
[6] WOLFF N A，ABOUHAMED M, VERROUST P J, et al. Megalin-dependent internalization of Cadmium-Metallothionein and cytotoxicity in cultured renal proximal tubule cells [J]. J Pharmacol Exp Ther, 2006, 318(2): 782-791.
[7] WHITE H S, SCHOLL E A, KLEIN B D, et al. Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models [J]. Neurotherapeutics, 2009, 6(2): 372-380.
[8] RUNESSON J, SAAR I, LUNDSTRM L, et al. A novel GalR2-specific peptide agonist [J]. Neuropeptides, 2009, 43(3): 187-192.
[9] PANDEY K N. Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif [J]. Mol Cell Biochem, 2010, 334(1-2): 81-98.
[10] XIE B, JIN S L, TANG C. Effect of peptide-galactoside-ADM liposome on target therapy of human hepatocellular carcinoma[J]. Prog Mod Biomed（现代生物医学进展）， 2008, 8(3): 441-444.
[11] ZHENG Y, SONG X, DARBY M, et al. Preparation and characterization of folate-poly(ethylene glycol)-grafted-trimethylchitosan for intracellular transport of protein through folate receptor-mediated endocytosis [J]. J Biotechnol, 2010, 145(1): 47-53.
[12] YELLEPEDDI V K, KUMAR A, PALAKURTHI S. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro [J]. Anticancer Res, 2009, 29(8): 2933-2943.
[13] GUPTA Y, KOHLI D V, JAIN S K. Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents [J]. Crit Rev Ther Drug Carrier Syst, 2008, 25(4): 347-379.
[14] RUIZ-SNCHEZ P, KNIG C, FERRARI S, et al. Vitamin B12 as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies [J]. J Biol Inorg Chem, 2011, 16（1）：33-44.
[15] CHEN F， WANG L Y， YI W D. Progress on function and influence factors of low density lipoprotein receptors[J]. Chin J Arterioscler（中国动脉硬化杂志）， 2006, 14(5): 448-450.
[16] NIKANJAM M, GIBBS A R, HUNT C A, et al. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme [J]. J Controlled Release, 2007, 124(3): 163-171.
[17] GRESSNER O A, LAHME B, GRESSNER A M. Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca2+-dependent interaction with the megalin/gp330 receptor [J]. Clinica Chimica Acta, 2008, 390(1/2): 28-37.
[18] ZHANG H M. Structure, expression and function of transferring receptor[J]. J Clin Med Pract（实用临床医药杂志）, 2008, 12(3): 114-117.
[19] JIANG C , JALLOULI Y, KROUBI M, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier [J]. Int J Pharm, 2009, 379(2): 285-292.
[20] STEINHAUSER I, LANGER K, STREBHARDT K, et al. Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells [J]. Biomaterials, 2006, 27(28): 4975-4983 .
[21] NAGAYAMA S, OGAWARA K, MINATO K, et al. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor [J]. Int J Pharm, 2007, 329(1/2): 192-198.
[22] JIANG H L, KANG M L, QUAN J S, et al. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization [J]. Biomaterials, 2008, 29(12): 1931-1939.
[23] FOSS F. Clinical experience with denileukin diftitox (ONTAK) [J]. Semin Oncol, 2006, 33(3): 11-16.
[24] PHILLIPS S M, BHOPALE M K, HILLIARD B, et al. Suppression of murine experimental autoimmune encephalomyelitis by interleukin-2 receptor targeted fusion toxin, DAB₃₈₉IL-2 [J]. Cell Immunol, 2010, 261(2): 144-152.
[25] KIM B H, YOON J H, MYUNG S J, et al. Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells [J]. Cancer Lett, 2009, 274(2): 259-265.
[26] MITSUKAWA K, LU X, BARTFAI T. Galanin, galanin receptors and drug targets [J]. Cell Mol Life Sci, 2008, 65(12): 1796-1805.
[27] BURIAN B, STORKA A, MARZLUF B A, et al. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients [J]. Peptides, 2010, 31(4): 603-608.
[28] ORTNER A, WERNIG K, KAISLER R, et al. VPAC Receptor mediated tumor cell targeting by protamine based nanoparticles [J]. J Drug Target, 2010, 18(6): 457-467.
[29] NYKSEL H, MOHANTY P S, RUBINSTEIN I. Vip-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: A novel targeted nanomedicine for breast cancer [J]. Int J Pharm, 2009, 365(1-2): 157-161.
[30] DREADEN E C, MWAKWARI S C, SODJI Q H, et al. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment [J]. Bioconjug Chem, 2009, 20(12): 2247-2253.